Latest news
MIMA will pitch at the “Women’s Health” focused session during the “Innovation for Health” conference, in Utrecht, The Netherlands, on March 26, 2026.
March 8, 2026
MIMA is among the 10 companies selected to present their projects on March 26th during the "Women's Health" pitch session of the 13th edition of “Innovation for Health" conference in Utrecht, the Netherlands.
This event aims to connect key players, innovators, entrepreneurs, and investors in the health and life sciences sector.
MIMA is participating in the TAU20 Impact Readiness Sprints supported by EBAN (European Business Angel Network) on March 13, 20 and 27.
March 6, 2026
MIMA was selected in the first cohort of startups to participate in the “TAU20 Impact Readiness Sprints” program.
Across 3 interactive sessions, we’ll turn our impact into clear KPIs, SDG alignment, IRIS+ metrics, and validated evidence, and get direct exposure to impact VCs and business angels.
Tau20 is the next-generation AI solution enabling founders and investors to generate systemic, measurable, and regenerative impact.
MIMA will participate in the 2026 “IEEE International Microwave Biomedical Conference” (“IMBioC 2026”) on April 26-29.
March 4, 2026
MIMA will contribute to the session “Microwave Imaging and Diagnostics: Advances in Hardware Solutions” by presenting its accepted scientific review paper, entitled “Microwave Breast Imaging - Technological Evidence, Clinical Needs, Expectations: A Review”.
“IMBioC” is an international forum on state-of-the-art research in radiofrequencies and microwaves, antennas, and electromagnetic theory and technology, bridging the gap between science and engineering applied to biomedical systems.
It is organized this year by University of Calabria in Cosenza, Italy.
MIMA will be integrated in the EGG Accelerator Programme, as of January 1st, 2026.
November 24, 2025
MIMA Technologies P.C. has been selected to join the EGG Accelerator, one of the most successful business accelerators in Greece!
The 12-month business acceleration programme is addressed to companies and business teams at the pre-seed, seed and early stage of development.
